跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Isobutyramide
首页
药物
Isobutyramide
Investigational
Small Molecule
Isobutyramide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
4
H
9
NO
CAS 编号
563-83-7
UNII ID
82UOE7B38Z
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
CN 1537025 A
申请人: HOFFMANN LA ROCHE
优先权: 2001
CN
US
3 件公开
Hexahydropyrazolo[4,3,-c]pyridine metabolites
US 2002002138 A1
申请人: KHOJASTEH S CYRUS
优先权: 2001
US
2 件公开
Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 lambda6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide
US 7160881 B2
申请人: HOFFMANN LA ROCHE
优先权: 2003
US
2 件公开
2-(3,5-bi-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-yl-4-o-tolyl-pyridine-3-yl)-isobutyramide
CN 1152016 C
申请人: HOFFMANN LA ROCHE
优先权: 1999
CN
Use of NK-1 receptor antagonists against benign prostatic hyperplasia
US 2003004157 A1
申请人: BUSER SUSANNE
优先权: 2001
US
Preparation method for 8-benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazole-4-base)-8-azabicyclo[3.2.1]octane
CN 102584814 A
申请人: UNIV ZHEJIANG
优先权: 2012
CN
Polymorph forms
US 9499543 B2
申请人: RAQUALIA PHARMA INC
优先权: 2014
US
Netupitant free alkali crystal form A and preparation method thereof
CN 106892864 A
申请人: SHANGHAI SYNCORES TECH INC
优先权: 2015
CN
Isobutyramide derivative and application thereof
CN 111329775 A
申请人: FUJIAN LIANKE TECH CO LTD
优先权: 2020
CN
Novel isobutyramide derivatives, cosmetic and/or dermatological preparations containing such compounds, and use thereof for preventing and treating sensitive, in particular inflamed skin or inflammatory skin conditions
CN 116096346 A
申请人: BEIERSDORF AS
优先权: 2020
CN
第 1 / 2 页
上一页
下一页
药物
反馈